drugset / Trial / NCT01244633

Ecopipam Treatment of Tourette Syndrome

NCT01244633

Phase 1/2 Completed 18 enrolled Psyadon Pharma
NaSingle-groupOpen-labelTreatment

Summary

Tourette's Syndrome is a neurological disease characterized by verbal and motor tics. The currently available drug treatments are considered to be inadequate. This clinical trial is designed to test if ecopipam is effective for the treatment of Tourette's Syndrome in adults.

Timeline

Start
2010-10
Primary completion
2012-07
Completion
2013-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Ecopipam Small molecule 50 mg
Subject Ecopipam Small molecule 100 mg

Indications